Used in biomedical research to detect and quantify levels of galactose-deficient IgA1 antibodies in human serum or plasma. This kit is essential for studying the pathogenesis of IgA nephropathy (IgAN), an autoimmune kidney disease where elevated levels of GD-IgA1 are a key biomarker. Researchers use this assay to investigate immune dysregulation, identify patients with high risk of disease progression, and evaluate potential therapeutic targets. It supports clinical studies and drug development by providing a reliable, sensitive, and specific measurement of GD-IgA1, aiding in early diagnosis and monitoring of IgA-related disorders.